Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.110
-0.190 (-4.42%)
At close: Jun 5, 2026, 4:00 PM EDT
3.960
-0.150 (-3.65%)
After-hours: Jun 5, 2026, 7:05 PM EDT
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $213.42 million as of June 5, 2026. Its market cap has increased by 434.73% in one year.
Market Cap
213.42M
Enterprise Value
116.33M
1-Year Change
434.73%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $213.42M, an increase of 2.33%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 213.42M | -32.89% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Q32 Bio | 222.30M |
| Cellectis | 221.33M |
| LENZ Therapeutics | 219.79M |
| Adagene | 219.36M |
| Foghorn Therapeutics | 219.00M |
| YD Bio | 211.66M |
| Cybin | 207.65M |
| Arcturus Therapeutics Holdings | 207.49M |